Ryan's Quest Advisory Board
Executive Board
President
David Schultz – Co-Founder & Ryan’s Dad
Vice President
Maria Schultz – Co-Founder & Ryan’s Mom
Chairman of the Board
Jeannine Cimino – Berkshire Bank
Vice-Chairman of the Board
Matthew Candelori – Kramer Beverage
Secretary
Andrea Meier – AAA Mid-Atlantic
Treasurer
Linda Ialacci – Linda Ialacci CPA, LLC
Legal Counsel
Crivelli & Barbati – Hamilton NJ
Board of Directors
Jessie Armstead – NY GIANTS & Hamilton Honda
Chris Cline – GEICO Hamilton
Justin Coecliff – Bank of America Merrill Lynch
Stacy Cucchiaro – Investors Bank
Tracey Destribats – Trenton Catholic Academy
Thomas W. Halm, Jr., Esq. – Halm Law Group, LLC.
Brian Klabbatz – Pennsylvania Steel Co., Inc.
Norman Koenigsberg - First Choice Loan Services
Pat Locane – State of New Jersey
Kevin Manna – Jersey Mike's
Joseph Vasta - JET Electric Testing, LLC
Lisa Schaible – Investors Bank
Nina Melker – Berkshire Bank
Denise Powers – Berkshire Bank
John Rossi – Arora & Associates, PC
Bill Rue Jr. – Rue Insurance
Michael A. Sabo – Pulse Media
Michael Saporito – Hamilton Honda
Andrew Sklarz – CURE Insurance Arena
Benny Tramo – Bloomberg LP
Cory Zeiter – Mixbin
Scientific Advisors
Carlo Rago, PhD
Johns Hopkins
Dr. Rago received his PhD in Cellular and Molecular Medicine from the Johns Hopkins School of Medicine. He was a recipient of the Ruth L. Kirschstein National Research Service Award, continuing his work in the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins as a post-doctoral fellow in the Vogelstein lab. He co-authored over 30 papers in high-profile journals and helped co-develop a comprehensive genetic test for Duchenne muscular dystrophy. He has also participated in discussions at the Food and Drug Administration (FDA) to help develop a framework to understand patient perspectives and help define "permissible risk" for clinical trial regulatory decisions. He also formally lobbied the FDA to include DMD in PDUFA-V.
Dr. Rago was the recipient of the Ryan's Quest HERO award in 2012 and has been invited to speak around the world to promote transparency, collaboration, and biomedical progress.
Joshua Selsby, PhD
Iowa State University